For the Inventor, By the Inventor

Enter assignee name

Lausanne, Switzerland

Ac Immune Sa

USPTO Granted Patents = 63

CIPO Patents = 9

EPO Patents = 43

Trademarks = 3

Forward Citations = 305

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Andreas Muhs (33 out of 34 patents)

Andrea M Pfeifer (26 out of 36 patents)

Oskar Adolfsson (17 out of 17 patents)

4. Maria Pihlgren (17 out of 17 patents)

5. David T Hickman (13 out of 13 patents)

6. Ryan Jefferson Watts (10 out of 38 patents)

7. Maria Pihlgren Bosch (9 out of 9 patents)

8. Heiko Kroth (8 out of 9 patents)

9. Isidro Hotzel (8 out of 17 patents)

10. Marija Vukicevic Verhille (7 out of 7 patents)

11. Emanuele Gabellieri (6 out of 8 patents)

12. Gai Ayalon (6 out of 7 patents)

13. Danielle Marie Di Cara (6 out of 6 patents)

14. Wolfgang Froestl (6 out of 11 patents)

15. Fred Van Leuven (6 out of 6 patents)

Core Competencies:

Phosphorylated Tau Peptide Vaccine

Anti-Abeta Therapeutic Vaccines

Tau Protein Aggregates

Anti-Tau Antibodies

Mimotopes of Alpha-Synuclein

Amyloid-Like Proteins

Humanized Antibodies

Vaccine Engineering

Monoclonal Antibodies

Ocular Disease Treatment

Pharmaceutical Composition

Nucleic Acid Molecules

63 patents: Sort by Forward Citations

1. 12324855 - Method of safe administration of phosphorylated Tau peptide vaccine (2025-06-10),

2. 12290553 - Method for vaccination against a self-antigen in a human patient (2025-05-06),

3. 12202840 - Compounds for the treatment or alleviation of disorders associated with Tau aggregates (2025-01-21),

4. 12005102 - Anti-abeta therapeutic vaccines (2024-06-11),

5. 11958889 - Compositions of phosphorylated tau peptides and uses thereof (2024-04-16),

6. 11814378 - Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates (2023-11-14),

7. 11684625 - Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates (2023-06-27),

8. 11684576 - Method of safe administration of phosphorylated tau peptide vaccine (2023-06-27),

9. 11623931 - Bicyclic compounds for diagnosis and therapy (2023-04-11),

10. 11591377 - Heterologous administration of tau vaccines (2023-02-28),

11. 11555065 - Anti-Tau antibodies and methods of use (2023-01-17),

12. 11534484 - Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy (2022-12-27),

13. 11466077 - Misfolded TDP-43 binding molecules (2022-10-11),

14. 11427629 - Anti-Tau antibodies and methods of use (2022-08-30),

15. 11352419 - Anti-tau antibodies and methods of use (2022-06-07),

AC Immune SA is a clinical-stage biopharmaceutical company, which develops treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. The company's unique drug discovery platform allows it to accurately target misfolded proteins associated with these diseases. AC Immune's pipeline includes a variety of candidates in different stages of development, and it collaborates with other leading pharmaceutical companies to bring innovative therapies to patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

63 Patents

#9 in Lausanne

#231 in Switzerland

#11,205 in the World

Lausanne, Switzerland

Ac Immune Sa

Forward Citations = 305

65 inventors:

Andreas Muhs (33 out of 34 patents)

Andrea M Pfeifer (26 out of 36 patents)

Oskar Adolfsson (17 out of 17 patents)

4. Maria Pihlgren (17 out of 17 patents)

5. David T Hickman (13 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…